CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 49 filers reported holding CONSTELLATION PHARMCETICLS I in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $21,242,000 | +4817.1% | 628,458 | +3299.5% | 0.00% | – |
| Q1 2021 | $432,000 | +4.9% | 18,487 | +29.0% | 0.00% | – |
| Q4 2020 | $412,000 | +81.5% | 14,332 | +25.3% | 0.00% | – |
| Q3 2020 | $227,000 | -17.2% | 11,442 | +25.2% | 0.00% | – |
| Q2 2020 | $274,000 | +42.7% | 9,140 | +49.1% | 0.00% | – |
| Q1 2020 | $192,000 | -33.1% | 6,129 | +0.5% | 0.00% | – |
| Q4 2019 | $287,000 | +769.7% | 6,098 | +20.3% | 0.00% | – |
| Q3 2019 | $33,000 | -23.3% | 5,068 | +19.4% | 0.00% | – |
| Q2 2019 | $43,000 | -17.3% | 4,246 | +10.3% | 0.00% | – |
| Q1 2019 | $52,000 | +550.0% | 3,848 | +86.0% | 0.00% | – |
| Q4 2018 | $8,000 | +33.3% | 2,069 | +121.3% | 0.00% | – |
| Q3 2018 | $6,000 | – | 935 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $37,259,000 | 42.17% |
| Svennilson Peter | 4,677,939 | $57,446,000 | 16.42% |
| VHCP Management II, LLC | 726,677 | $8,924,000 | 2.81% |
| Casdin Capital, LLC | 1,523,960 | $18,714,229,000 | 1.75% |
| P.A.W. CAPITAL CORP | 120,000 | $1,474,000 | 1.59% |
| Cormorant Asset Management, LP | 1,271,685 | $15,616,000 | 0.90% |
| VHCP Management III, LLC | 66,667 | $819,000 | 0.38% |
| Orbimed Advisors | 835,842 | $10,264,000 | 0.16% |
| Hillhouse Capital Management | 317,921 | $3,904,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,600 | $2,255,000 | 0.08% |